US › Healthcare

Avantor Inc (AVTR)

US · Healthcare · Medical Instruments & Supplies

$13.68+0.07%
Last close · 2026-08-04

Latest quarter · ended 2026-06-30

Revenue
$1.69B
Revenue YoY
+0.5%
Net profit
$38.1M
Profit YoY
-41.1%
EPS
$0.24
EPS estimate
$0.19
Net margin
2.3%

EPS came in at 0.24 against a street estimate of 0.19 — a beat of 26.3%.

Key statistics

Market cap
$9.25B
Forward P/E
16.9
P/B
1.66
Book value
$8.32
EPS (TTM)
$-0.85
52-week high
$15.93
52-week low
$7.26
50-day MA
$10.17
200-day MA
$10.23
Beta
0.89

Analyst view

Analysts rate Avantor Inc a buy (10 buy, 11 hold, 0 sell out of 21) with an average price target of $10.44.

Shareholding

Insiders
1.49%
Institutions
102.66%

Largest institutional holders

FundStake
Dodge & Cox17.52%
BlackRock Inc9.62%
Vanguard Group Inc9.51%
Vanguard Portfolio Management, LLC4.58%
Vanguard Capital Management, LLC4.48%
Wellington Management Company LLP3.55%
Greenhaven Associates Inc3.31%
Barrow Hanley Mewhinney & Strauss LLC3.27%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Avantor Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.